Assenagon Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Assenagon Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,228	Closed	-$1.1M	–	1617
2022 Q1	$1.1M	Sell	54,228 -217,670	-80%	-$4.43M	﹤0.01%	1029
2021 Q4	$7.93M	Buy	271,898 +161,154	+146%	+$4.61M	0.02%	390
2021 Q3	$2.39M	Buy	+110,744	New	+$2.67M	0.01%	640
2021 Q2	–	Sell	-57,367	Closed	-$1.05M	–	1443
2021 Q1	$1.05M	Sell	57,367 -63,136	-52%	-$1.05M	﹤0.01%	919
2020 Q4	$1.39M	Buy	+120,503	New	+$1.1M	0.01%	626

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Assenagon Asset Management's CDMO Position: Q2 2022 in Review

Assenagon Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 54,228 shares — an estimated $1.1M sold.

Assenagon Asset Management first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $7.93M in Q4 2021. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

Assenagon Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Assenagon Asset Management sold 54,228 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $1.1M.
Assenagon Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Assenagon Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $7.93M in Q4 2021.
187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.